학술논문

Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway
Document Type
Article
Source
Regulatory Peptides. Mar2013, Vol. 182, p53-58. 6p.
Subject
*UROTENSINS
*COLLAGEN
*MUSCLE cell culture
*TRANSFORMING growth factors-beta
*CELLULAR signal transduction
*LABORATORY rats
*CHEMICAL synthesis
Language
ISSN
0167-0115
Abstract
Abstract: Background: Recent studies suggest that urotensin II (UII) and transforming growth factor-β1 (TGF-β1) both have critical roles in vascular remodeling. UII is a recently discovered vasoconstrictive peptide that is involved in the pathogenesis of atherosclerosis, restenosis and hypertension. TGF-β1 is an important factor that has a pivotal role in vascular fibrosis. This study aimed to explore whether TGF-β1 is involved in UII-induced collagen synthesis in rat aortic vascular smooth muscle cells (VSMCs) and examined the effects and mechanisms of UII on collagen synthesis and secretion in VSMCs. Methods: VSMCs were prepared by the explant culture method. TGF-β1 and collagen I secretions from the cells were determined by enzyme-linked immunosorbent assay (ELISA). The mRNA and protein expressions of TGF-β1, collagen I, Smad2 and Smad3 were determined using Real-time RT-PCR and Western blotting. Results: UII dose-dependently promoted TGF-β1 protein expression and secretion from VSMCs, with maximal effect at 10−8 mol/l at 24h for protein expression and 10−7 mol/l at 24h for protein secretion (both P<0.01). Moreover, UII dose-dependently promoted Smad2 and Smad3 mRNA expression in VSMCs, with maximal effect at 10−8 mol/l for 12h (both P<0.01). The effects of UII were significantly inhibited by its receptor antagonists urantide (10−6 mol/l) or SB-710411 (10−6 mol/l), and by the mitogen-activated protein kinase (MAPK/ERK) inhibitor PD98059 (10−6 mol/l). UII dose-dependently promoted collagen I mRNA expression and protein secretion in VSMCs, with maximal effect at 10−8 mol/l at 12h for mRNA expression and 10−6 mol/l at 24h for protein secretion (both P<0.01). Collagen synthesis and secretion from VSMCs induced by UII were inhibited significantly by a TGF-β1-specific neutralizing antibody, SB-431542 (an antagonist of the TGF-β1 type II receptor) and PD98059 (all P<0.01). Conclusions: This study suggests that UII could induce collagen synthesis and secretion through upregulation of TGF-β1 expression and secretion in VSMCs, and that TGF-β1/Smad2/3 signaling might be one of the important pathways by which UII is involved in vascular fibrosis. [Copyright &y& Elsevier]